[go: up one dir, main page]

NO20063308L - Kombinasjon av flupirtin og tramadol - Google Patents

Kombinasjon av flupirtin og tramadol

Info

Publication number
NO20063308L
NO20063308L NO20063308A NO20063308A NO20063308L NO 20063308 L NO20063308 L NO 20063308L NO 20063308 A NO20063308 A NO 20063308A NO 20063308 A NO20063308 A NO 20063308A NO 20063308 L NO20063308 L NO 20063308L
Authority
NO
Norway
Prior art keywords
flupirtine
tramadol
combination
treament
pain
Prior art date
Application number
NO20063308A
Other languages
English (en)
Other versions
NO335734B1 (no
Inventor
Istvan Szelenyi
Joachim Maus
Peter Juergen Cnota
Original Assignee
Viatris Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Viatris Gmbh filed Critical Viatris Gmbh
Publication of NO20063308L publication Critical patent/NO20063308L/no
Publication of NO335734B1 publication Critical patent/NO335734B1/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A61K31/137—Arylalkylamines, e.g. amphetamine, epinephrine, salbutamol, ephedrine or methadone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/12—Drugs for disorders of the urinary system of the kidneys
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00—Drugs for disorders of the muscular or neuromuscular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/06—Antimigraine agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Neurology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Epidemiology (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Emergency Medicine (AREA)
  • Urology & Nephrology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Compositions Of Macromolecular Compounds (AREA)
  • Artificial Filaments (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

Emneområde av den foreliggende oppfinnelsen er å tilveiebringe en kombinasjon av to sentralt virkende analgetika, flupirtin og tramadol, eller deres respektive farmasøytisk akseptable salter for behandlingen av smerte.
NO20063308A 2003-12-17 2006-07-17 Anvendelse av flupirtin og tramadol i kombinasjon for behandling av smerte NO335734B1 (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US52976103P 2003-12-17 2003-12-17
PCT/EP2004/014025 WO2005058420A1 (en) 2003-12-17 2004-12-09 Combination of flupirtine and tramadol

Publications (2)

Publication Number Publication Date
NO20063308L true NO20063308L (no) 2006-09-12
NO335734B1 NO335734B1 (no) 2015-02-02

Family

ID=34700037

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20063308A NO335734B1 (no) 2003-12-17 2006-07-17 Anvendelse av flupirtin og tramadol i kombinasjon for behandling av smerte

Country Status (18)

Country Link
US (1) US7553858B2 (no)
EP (1) EP1697005B1 (no)
JP (1) JP4933265B2 (no)
CN (1) CN1889996A (no)
AT (1) ATE525112T1 (no)
AU (1) AU2004298333B2 (no)
CA (1) CA2546302C (no)
DK (1) DK1697005T3 (no)
ES (1) ES2373957T3 (no)
HR (1) HRP20110914T1 (no)
MX (1) MXPA06006999A (no)
NO (1) NO335734B1 (no)
NZ (1) NZ547256A (no)
PL (1) PL1697005T3 (no)
PT (1) PT1697005E (no)
RU (1) RU2463042C2 (no)
SI (1) SI1697005T1 (no)
WO (1) WO2005058420A1 (no)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20060052370A1 (en) * 2004-08-24 2006-03-09 Meyerson Laurence R Methods and compositions for treating nociceptive pain
US7619007B2 (en) 2004-11-23 2009-11-17 Adamas Pharmaceuticals, Inc. Method and composition for administering an NMDA receptor antagonist to a subject
BRPI0607017B8 (pt) 2005-04-06 2021-05-25 Adamas Pharmaceuticals Inc composição farmacêutica compreendendo memantina e donezepil, e seu uso para o tratamento de condições relacionadas ao snc
WO2008134048A2 (en) * 2007-04-27 2008-11-06 Paratek Pharmaceuticals, Inc. Methods for synthesizing and purifying aminoalkyl tetracycline compounds
CN102333532A (zh) * 2009-01-30 2012-01-25 瑞乐威尔澳大利亚私人有限公司 药物抗滥用,方法及组合物
DE102010063612A1 (de) 2010-12-20 2012-06-21 Awd.Pharma Gmbh & Co. Kg Neue Multikomponentenkristalle aus ([2-Amino-6-(4-fluoro-benzylamino)-pyridin-3-yl]-carbamidsäureethylester und 2-[2-[(2,6-Dichlorphenyl)-amino]-phenyl]-essigsäure
DE102010063609A1 (de) 2010-12-20 2012-06-21 Awd.Pharma Gmbh & Co. Kg Neue Multikomponentenkristalle aus ([2-Amino-6-(4-fluoro-benzylamino)-pyridin-3yl)-carbamidsäureethylester und einer Arylpropionsäure
MX2014010460A (es) * 2012-03-02 2014-10-13 Meda Pharma Gmbh & Co Kg Formulaciones farmaceuticas que contienen flupirtina.
US9693949B1 (en) 2015-12-22 2017-07-04 Revogenex Ireland Ltd Intravenous administration of tramadol
US9980900B2 (en) 2015-12-22 2018-05-29 Revogenex Ireland Ltd Intravenous administration of tramadol
RU2678976C1 (ru) * 2018-03-21 2019-02-05 федеральное государственное бюджетное образовательное учреждение высшего образования "Тверской государственный медицинский университет" Министерства здравоохранения Российской Федерации Способ профилактики длительного болевого синдрома в отдаленном послеоперационном периоде у пациентов с дисплазией соединительной ткани
TWI886158B (zh) 2019-10-10 2025-06-11 加拿大商再諾製藥公司 選擇性鉀通道調節劑之固態晶型
BR112022010733A2 (pt) * 2019-12-06 2022-08-23 Xenon Pharmaceuticals Inc Métodos para tratar dor

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH0532627A (ja) * 1991-07-29 1993-02-09 Asta Medica Ag 筋肉痙攣により帰因するか又は筋肉痙攣の結果である疾病及び症候群を治療するための医薬品及びその製法
DE4236752A1 (de) * 1992-10-30 1994-05-05 Asta Medica Ag Kombinationspräparat aus Flupirtin und Morphin zur Behandlung von Schmerzen und zur Vermeidung der Morphin-Abhängigkeit
DE19807535A1 (de) * 1998-02-21 1999-08-26 Asta Medica Ag Pharmazeutische Kombinationen mit Tramadol
HUP0301296A2 (hu) * 1999-08-03 2003-08-28 Awd.Pharma Gmbh & Co. Kg Flupirtin alkalmazása degeneratív ízületi fájdalom kezelésére

Also Published As

Publication number Publication date
EP1697005B1 (en) 2011-09-21
AU2004298333B2 (en) 2009-12-17
CN1889996A (zh) 2007-01-03
MXPA06006999A (es) 2006-12-14
DK1697005T3 (da) 2011-12-12
EP1697005A1 (en) 2006-09-06
NO335734B1 (no) 2015-02-02
PL1697005T3 (pl) 2012-02-29
WO2005058420A1 (en) 2005-06-30
CA2546302C (en) 2012-05-22
RU2463042C2 (ru) 2012-10-10
RU2006125520A (ru) 2008-01-27
AU2004298333A1 (en) 2005-06-30
ATE525112T1 (de) 2011-10-15
JP4933265B2 (ja) 2012-05-16
JP2007514672A (ja) 2007-06-07
HRP20110914T1 (hr) 2011-12-31
US7553858B2 (en) 2009-06-30
ES2373957T3 (es) 2012-02-10
US20050137235A1 (en) 2005-06-23
SI1697005T1 (sl) 2012-01-31
CA2546302A1 (en) 2005-06-30
NZ547256A (en) 2009-04-30
PT1697005E (pt) 2011-12-29

Similar Documents

Publication Publication Date Title
DE60223254D1 (de) Verzögert freisetzende formulierungen von oxymorphon
NO2012009I2 (no) Kombinasjonsprodukt av saxaglipin og metformin og farmasøytisk akseptable salter derav, herunder HCIsaltene av saxaglipin og metformin
CY1105082T1 (el) Χρηση της φλιβανσepινης στην αγωγη διαταραχων της σεξουαλικης επιθυμιας
CY2009002I2 (el) Χρηση αμινοξικων αντισπασμωδικων για τη θεραπευτικη αγωγη του πονου
DK1178958T3 (da) N-cyanomethylamider som proteaseinhibitorer
SE0101387D0 (sv) Novel compounds
NO20063308L (no) Kombinasjon av flupirtin og tramadol
NO20045065L (no) Nytt formatsalt av o-desmetyl-venlafaxin
NO20035773L (no) Ny konstruert superantigen for human terapi
DK1537096T3 (da) Derivater af dioxan-2-alkylcarbamater, fremstilling og terapeutisk anvendelse heraf
NO20034863D0 (no) Deuterert 3-piperidinopropiofenon og medikamenter inneholdende disse
DK1513835T3 (da) Piperazinylacylpiperidinderivater, fremstilling og terapeutisk anvendelse heraf
DK1590321T3 (da) Arylalkylcarbamat-derivater, fremstilling og terapeutisk anvendelse deraf
DK1404304T3 (da) Tablet omfattende cetirizin og pseudoephedrin
DK1417189T3 (da) Acylaminothiazolderivater, fremstilling og terapeutisk anvendelse heraf
NO20024838L (no) Salter av bicykliske, N-acylerte imidazo-3-aminer og imidazo- 5-aminer
DK1525193T3 (da) Acylaminothiazolderivater, deres fremstilling og deres terapeutiske anvendelse
DK1556382T3 (da) 3-Phenylpyridoindolderivater, fremstilling og terapeutisk anvendelse deraf
AU2002332488A8 (en) R-bambuterol, its preparation and therapeutic uses
DK1553950T3 (da) Terapeutisk behandling
NO20050689L (no) Terapeutisk anvendelse
ATE325115T1 (de) Pyrimidinderivate als selektive cox-2-inhibitoren
DK1353912T3 (da) 2-Arylimino-2,3-dihydrothiazolderivater, fremgangsmåderne til deres fremstilling og deres terapeutiske anvendelse
ATE343576T1 (de) 7-azaindolderivate als cox2-inhibitoren
UY26990A1 (es) Nuevas composiciones de medicamentos

Legal Events

Date Code Title Description
CHAD Change of the owner's name or address (par. 44 patent law, par. patentforskriften)

Owner name: MEDA PHARMA GMBH & CO KG, DE

MM1K Lapsed by not paying the annual fees